Certain Chinese medicines can regulate neurotrophic and apoptosis-related factors

NewsGuard 100/100 Score

Parkinson's disease is a common neurodegenerative disease in the elderly, which is pathologically characterized by selective loss of dopaminergic neurons. Compound preparations of Chinese medicines that can tonify the kidney have been reported to significantly improve symptoms of Parkinson's disease. However, the mechanism of action remains unclear. To investigate whether Chinese medicines that tonify the kidney can protect in vitro cultures of dopaminergic neurons, a recent study published in the Neural Regeneration Research (Vol. 8, No. 30, 2013) showed that Chinese medicines used for tonifying the kidney, such as Herba Epimedii and Herba Cistanches, can protect nerve cells by regulating the expression of apoptosis-related factors and neurotrophic factors.

Article: " How do Chinese medicines that tonify the kidney inhibit dopaminergic neuron apoptosis? " by Shaogang Lin1, Shuifen Ye2, Jinmu Huang1, Yun Tian3, Yihui Xu2, Mengqi Wu2, Jingxia Wang2, Songying Wu4, Jing Cai2 (1 Hospital of Putian University, Putian 351100, Fujian Province, China; 2 Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, Fujian Province, China; 3 College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, Zhejiang Province, China; 4 The Second People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou 350003, Fujian Province, China)

Lin SG, Ye SF, Huang JM, Tian Y, Xu YH, Wu MQ, Wang JX, Wu SY, Cai J. How do Chinese medicines that tonify the kidney inhibit dopaminergic neuron apoptosis? Neural Regen Res. 2013;8(30):2820-2826.

Source: Neural Regeneration Research

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
NUS study reveals key mechanisms behind drug resistance in relapsed acute myeloid leukemia